Stock & Company Details
Denali Therapeutics Inc $DNLI
Price:
N/A
N/A
160M
$3.9B
52 Week High:
N/A
10 Day Average Volume:
N/A
-8.46
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
DNLI technical indicators
Latest Denali Therapeutics Inc (DNLI) indicator readings as of 2026-08-28.
DNLI's 14-day RSI is 46.7, in neutral territory. At $24.00 it is trading 15.9% above its 200-day moving average of $20.70, and below its 50-day average of $24.57. Price sits in the middle of its Bollinger Bands ($23.58 to $25.63). ADX reads 14.0, indicating a range-bound market rather than a trend.
Select a strategy to see its performance
Backtested on this stock over recent history.
| Strategy | Trend | Return | Win rate |
|---|---|---|---|
| MACD Momentum Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | – | – | |
| RSI Reversal Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | – | – | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | – | – | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | – | – |
Overview
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.
Finance Bot
Ask your questions
Start by typing a question below.
